IL326645A - Pharmaceutical compositions comprising a pkc inhibitor - Google Patents

Pharmaceutical compositions comprising a pkc inhibitor

Info

Publication number
IL326645A
IL326645A IL326645A IL32664526A IL326645A IL 326645 A IL326645 A IL 326645A IL 326645 A IL326645 A IL 326645A IL 32664526 A IL32664526 A IL 32664526A IL 326645 A IL326645 A IL 326645A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
pkc inhibitor
pkc
inhibitor
pharmaceutical
Prior art date
Application number
IL326645A
Other languages
Hebrew (he)
Inventor
Xin Linghu
Sami Karaborni
Original Assignee
Ideaya Biosciences Inc
Xin Linghu
Sami Karaborni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ideaya Biosciences Inc, Xin Linghu, Sami Karaborni filed Critical Ideaya Biosciences Inc
Publication of IL326645A publication Critical patent/IL326645A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL326645A 2023-08-21 2024-08-21 Pharmaceutical compositions comprising a pkc inhibitor IL326645A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363520857P 2023-08-21 2023-08-21
PCT/US2024/043216 WO2025042981A2 (en) 2023-08-21 2024-08-21 Pharmaceutical compositions comprising a pkc inhibitor

Publications (1)

Publication Number Publication Date
IL326645A true IL326645A (en) 2026-04-01

Family

ID=94732761

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326645A IL326645A (en) 2023-08-21 2024-08-21 Pharmaceutical compositions comprising a pkc inhibitor

Country Status (4)

Country Link
CN (1) CN121889149A (en)
AU (1) AU2024327543A1 (en)
IL (1) IL326645A (en)
WO (1) WO2025042981A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3589B1 (en) * 2014-08-06 2020-07-05 Novartis Ag Protein kinase c inhibitors and methods of their use
AU2021213811A1 (en) * 2020-01-29 2022-07-28 Foghorn Therapeutics Inc. Compounds and uses thereof
US12383555B2 (en) * 2020-05-20 2025-08-12 Foghorn Therapeutics Inc. Methods of treating cancers

Also Published As

Publication number Publication date
WO2025042981A3 (en) 2025-04-24
CN121889149A (en) 2026-04-17
WO2025042981A2 (en) 2025-02-27
AU2024327543A1 (en) 2026-03-12

Similar Documents

Publication Publication Date Title
IL192357A0 (en) Pharmaceutical compositions containing a farnesyl transferase inhibitor
IL321625A (en) Malt1 inhibitors
IL304525A (en) Pharmaceutical composition comprising a diphenylpyrazine derivative
GB202008201D0 (en) Inhibitor compounds
IL314049A (en) Parp7 inhibitors
GB202004960D0 (en) Inhibitor compounds
GB202110373D0 (en) Inhibitor compounds
GB202300881D0 (en) Inhibitor compounds
IL326645A (en) Pharmaceutical compositions comprising a pkc inhibitor
CA3301500A1 (en) Pharmaceutical compositions comprising a pkc inhibitor
GB202307924D0 (en) Inhibitor compounds
IL313622A (en) Compositions comprising a chemokine receptor pathway inhibitor
AU2024217004A1 (en) Solid oral pharmaceutical compositions including alkyl 3,4,5‑trihydroxybenzoate as a nitrosamine inhibitor
IL319336A (en) Pharmaceutical forms of a cd73 inhibitor
IL314046A (en) Ribociclib pharmaceutical compositions
CA3298102A1 (en) Pharmaceutical compositions comprising a menin inhibitor
PL4279075T3 (en) A pharmaceutical composition comprising elagolix
HK40101114A (en) Pharmaceutical compositions of a kinase inhibitor
HK40079685A (en) Pharmaceutical compositions of a kinase inhibitor
GB202306601D0 (en) Inhibitor compounds
IL325676A (en) Kat6 inhibitor
GB202215245D0 (en) Inhibitor compounds
GB202207972D0 (en) Inhibitor compounds
HK40111764A (en) Compositions comprising a chemokine receptor pathway inhibitor
GB202418176D0 (en) Inhibitor compounds